Ghrelin and body weight regulation in the obese Zucker rat in relation to feeding state and dark/light cycle.
Ghrelin is a new orexigenic peptide primarily produced by the stomach but also present in the hypothalamus. It has adipogenic effects when it is chronically injected in rodents but in obese humans, its plasma concentration is decreased. It can reverse the anorectic effects of leptin when it is co-injected with this peptide in the brain ventricles. The Zucker fa/fa rat is a genetic model of obesity related to a default in the leptin receptor. It is characterized by a large dysregulation of numerous hypothalamic peptides but the ghrelin status of this rat has not yet been determined. Through several experiments, we determine in lean and obese Zucker rats its circulating form in the plasma, its tissue levels and/or expression, and studied the influence of different feeding conditions and its light/dark variations. Ghrelin expression was higher in the obese stomach and hypothalamus (P < 0.05 and P < 0.02, respectively). The ratio of [Octanoyl-Ser3]-ghrelin (active form) to [Des-Octanoyl-Ser3]-ghrelin (inactive form) was approximately 1:1 in the stomach and 2:1 in the plasma in lean and obese rats (no differences). After fasting, plasma ghrelin concentrations increased significantly in lean (+ 64%; P < 0.001) and obese (+ 60%; P < 0.02) rats. After 24 hours of refeeding, they returned to their initial ad lib levels. Ghrelin concentrations were higher in obese rats by 69% (P < 0.005), 65% (P < 0.02), and 73% (P < 0.005) in the ad libitum, fast, and refed states respectively. These results indicate that the obese Zucker rat is characterized by increases in the stomach mRNA expression and in peptide release in the circulation. They clearly support a role for ghrelin in the development of obesity in the absence of leptin signaling.
Beck
Bernard
B
Systèmes Neuromodulateurs des Comportements Ingestifs, Nancy, France. Bernard.Beck@nancy.inserm.fr
Richy
Sébastien
S
Stricker-Krongrad
Alain
A
D000818:Animals; D001835:Body Weight / Q000502:physiology*; D003624:Darkness; D004435:Eating / Q000502:physiology*; D005215:Fasting / Q000502:physiology; D005753:Gastric Mucosa / Q000378:metabolism; D005786:Gene Expression Regulation; D054439:Ghrelin; D007031:Hypothalamus / Q000737:chemistry / Q000378:metabolism; D020738:Leptin / Q000032:analysis; D008027:Light; D008297:Male; D036361:Peptide Hormones / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism*; D017440:Photoperiod; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D011863:Radioimmunoassay / Q000379:methods; D051381:Rats; D011924:Rats, Zucker; D013270:Stomach / Q000033:anatomy & histology / Q000737:chemistry
D054439:Ghrelin; D020738:Leptin; D036361:Peptide Hormones; D012333:RNA, Messenger